New Delhi, April 8 Zydus Lifesciences Ltd announced on Wednesday that it has received final approval from the US health regulator for its generic version of dapagliflozin tablets, indicated for controlling blood sugar in adults with type 2 diabetes mellitus.The approval from the US Food and...
ahmedabad
blood sugar control
dapagliflozin
diabetes mellitus
genericdrugs
pharmaceuticals
tablet formulation
type 2 diabetes
united states
usfda
zydus lifesciences
New Delhi, April 4 – India’s drug regulators are increasing their oversight of rapidly growing weight-loss and diabetes therapies, particularly GLP-1 receptor agonists, amid rising demand and the anticipated entry of cheaper generic versions into the domestic market.This move comes as the...
New Delhi, April 2 Emcure Pharmaceuticals announced on Thursday a reduction in the price of its weight management drug, Poviztra, a semaglutide injection, by up to 55 per cent to improve patient access.The starting dose of Poviztra (0.25 mg) will now be available for Rs 3,999 per month...
New Delhi, March 31 Novo Nordisk India announced on Tuesday reductions in the prices of Ozempic and Wegovy in India, days after the launch of generic versions of semaglutide injections for patients with type 2 diabetes and obesity.Indian pharmaceutical companies recently announced the launch...
cardiometabolic health
clinical evidence
diabetes
drug pricing
genericdrugs
healthcare costs
india
novo nordisk
obesity
ozempic
pharmaceuticals
semaglutide
treatment
type 2 diabetes
wegovy
New Delhi, March 30 Alembic Pharmaceuticals Ltd announced on Monday that it has received final approval from the US health regulator for its generic version of Paroxetine extended-release tablets, indicated for various mental health conditions.The approval from the US Food & Drug...
New Delhi, March 30 – India's pharmaceutical sector is poised to take a major step towards becoming a globally competitive powerhouse driven by innovation, according to the government, as India Pharma 2026 aims to accelerate the industry's transition from volume-based growth to value and...
biosimilars
department of pharmaceuticals
drug discovery
federation of indian chambers of commerce and industry
genericdrugs
global health
healthcare
india
india pharma 2026
innovation
pharmaceutical industry
pharmaceuticals
policy
research and development
supply chains
New Delhi, March 18 Zydus Lifesciences and Torrent Pharmaceuticals have signed a licensing and supply agreement to co-market the diabetes treatment medication Semaglutide Injection in the Indian market.Under the terms of the agreement, Zydus will manufacture and supply the product, while...
Washington, March 12 – The United States has become dangerously reliant on China for the raw materials and ingredients used in many of its most common medicines, lawmakers and expert witnesses warned at a Senate hearing, framing the issue as both a national security threat and an impending...
active pharmaceutical ingredients
arsenic
china
drug quality
genericdrugs
medicines
national security
pharmaceuticals
public health
raw materials
rosemary gibson
senate committee on aging
supply chain
ted yoho
thallium
united states
Washington, February 20 – Two top American Senators have written to the Secretary of War, Pete Hegseth, seeking details on vulnerabilities in America's pharmaceutical supply chain, warning that heavy reliance on foreign sources – particularly Communist China and India – could threaten military...
active pharmaceutical ingredients (apis)
china
department of defense
drug acquisition
fda exemptions
genericdrugs
india
national security
pharmaceutical supply chain
rare earth elements
starting materials (ksms)
tricare
united states government
united states senate
xinjiang region
New Delhi, February 13 Akums Drugs & Pharmaceuticals reported a 29.5 per cent increase in consolidated net profit to Rs 86 crore for the third quarter ended December 2025, on Friday.The company earned a net profit of Rs 66 crore in the October-December quarter of the previous fiscal year.Its...